You are viewing the site in preview mode

Skip to main content

Advertisement

Fig. 3 | Journal for ImmunoTherapy of Cancer

Fig. 3

From: Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

Fig. 3

Association between TIS score and overall survival in TCGA. a Forest plot showing log hazard ratio estimates and 95% confidence intervals. Cancers in which TIS score is statistically significantly (p < 0.05) associated with good prognosis are highlighted in blue; significant associations with poor prognosis are in red. b-e Kaplan-Meier curves of overall survival split by TIS score tertiles within 4 selected tumor types: melanoma, sarcoma, pancreatic adenocarcinoma, and lower grade glioma

Back to article page